Sensei Biotherapeutics Inc. (NASDAQ:SNSE) is one of the best performing NASDAQ stocks according to Wall Street analysts. On March 30, Sensei Biotherapeutics shifted its focus following the acquisition of Faeth Therapeutics and a concurrent $200 million private placement. The company’s lead program is now PIKTOR, an all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. This new […]
Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
238last 24h
1481last 7d
249● bullish (7d)
156● bearish (7d)
205publishers
Insider Monkey106d agoneutral
Sensei Biotherapeutics (SNSE): Best Performing NASDAQ Stocks According to Wall Street AnalystsPharmaceutical Technology292d agoneutral
Sensei to ditch its lead candidate and cut workforce amidst strategic reviewThe Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.